Larvol Delta - PureTech-Announces-Successful-EndofPhase-2-Meeting-with-FDA-for-Deupirfenidone-LYT100-in-Idiopathic-Pulmonary-Fibrosis

deupirfenidone (LYT-100) - PureTech

https://www.businesswire.com/news/home/20251207891734/en/PureTech-Announces-Successful-End-of-Phase-2-Meeting-with-FDA-for-Deupirfenidone-LYT-100-in-Idiopathic-Pulmonary-Fibrosis

Dec 8, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next